SOX2 is a SOXB1 family transcription factor containing an HMG-box domain that binds the minor groove of DNA and functions as a pioneer factor. As a core pluripotency factor (one of the Yamanaka factors), SOX2 maintains embryonic stem cell self-renewal and neural stem cell identity. It cooperates with OCT4 on composite Sox/Oct DNA motifs to regulate thousands of enhancers controlling pluripotency and early neural fate specification. SOX2 is essential for maintaining neural progenitor cells in an undifferentiated state and preventing premature neuronal differentiation. Nuclear localization is regulated by NLS/NES sequences and post-translational modifications including methylation, acetylation, SUMOylation, and ubiquitination.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Esophageal Atresia | susceptibility | |
| Isolated Anophthalmia-Microphthalmia Syndrome | causative |
mechanism: Eye Field Transcription Factor Network Dosage Loss
|
| Esophageal Squamous Cell Carcinoma |
untyped
Lineage Oncogene Amplification
|
mechanism: SOX2/TP63 Lineage Program Activation
|
| Laryngotracheoesophageal Cleft |
untyped
Associated
|
|
| Microphthalmia with Coloboma |
untyped
Causal dominant variant (often de novo)
|
mechanism: Disrupted optic-cup and globe morphogenesis
subtype: SOX2-MAC
scoped to subtype: SOX2-MAC
|
| Embryonal Carcinoma | no genetic record |
mechanism: Retained Embryonic Pluripotency Program
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.